Melanoma

Aggressive skin cancer arising from melanocytes, with BRAF and NRAS driver mutations amenable to targeted therapy.

适用于该病症的药物

Aldesleukin

CHEMBL1201438 · Protein

Phase 4

Anti-Melanoma Mab Fragments

CHEMBL5315106 · Antibody

Phase 4

Binimetinib

CHEMBL3187723 · Small molecule

Phase 4

Cobimetinib

CHEMBL2146883 · Small molecule

Phase 4

Dabrafenib

CHEMBL2028663 · Small molecule

Phase 4

Dabrafenib Mesylate

CHEMBL2105729 · Small molecule

Phase 4

Dacarbazine

CHEMBL476 · Small molecule

Phase 4

Fluorodopa

CHEMBL3547132 · Small molecule

Phase 4

Histamine

CHEMBL90 · Small molecule

Phase 4

Interferon Alfa-2A

CHEMBL2108508 · Protein

Phase 4

Interferon Alfa-2B

CHEMBL1201558 · Protein

Phase 4

Ipilimumab

CHEMBL1789844 · Antibody

Phase 4

Isosulfan Blue Inner Salt

CHEMBL1201275 · Small molecule

Phase 4

Lifileucel

CHEMBL4298200 · Cell

Phase 4

Phenformin

CHEMBL170988 · Small molecule

Phase 4

Relatlimab

CHEMBL3990044 · Antibody

Phase 4

Retifanlimab

CHEMBL4298037 · Antibody

Phase 4

Selumetinib

CHEMBL1614701 · Small molecule

Phase 4

Talimogene Laherparepvec

CHEMBL2108727 · Gene

Phase 4

Tarlatamab

CHEMBL5095292 · Antibody

Phase 4

Tasonermin

CHEMBL2107891 · Protein

Phase 4

Tazemetostat Hydrobromide

CHEMBL4594260 · Small molecule

Phase 4

Tebentafusp

CHEMBL4297990 · Protein

Phase 4

Technetium Tc 99M Sulfur Colloid

CHEMBL1201529 · Unknown

Phase 4

Technetium Tc 99M Tilmanocept

CHEMBL2108726 · Protein

Phase 4

Tilmanocept

CHEMBL5315077 · Small molecule

Phase 4

Toripalimab

CHEMBL4297843 · Antibody

Phase 4

Trametinib

CHEMBL2103875 · Small molecule

Phase 4

Trientine Hydrochloride

CHEMBL3989777 · Small molecule

Phase 4

Tyrosine

CHEMBL925 · Small molecule

Phase 4

Vemurafenib

CHEMBL1229517 · Small molecule

Phase 4

Related Conditions